Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?

Fibroblasts are the chief effector cells in fibrotic diseases and have been discovered to be highly heterogeneous. Recently, fibroblast heterogeneity in human skin has been studied extensively and several surface markers for dermal fibroblast subtypes have been identified, holding promise for future...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xin, Khoong, Yimin, Han, Chengyao, Su, Dai, Ma, Hao, Gu, Shuchen, Li, Qingfeng, Zan, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319956/
https://www.ncbi.nlm.nih.gov/pubmed/34335301
http://dx.doi.org/10.3389/fphys.2021.694605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319956/
https://www.ncbi.nlm.nih.gov/pubmed/34335301
http://dx.doi.org/10.3389/fphys.2021.694605

Ejemplares similares